High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
about
Intestinal epithelial apoptosis initiates gut mucosal injury during extracorporeal membrane oxygenation in the newborn pigletAlterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseasesDefective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patientsDetection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposisFas and Fas ligand in gut and liver.Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel diseaseApoptosis: implications for inflammatory bowel disease.Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis.Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling.Recent advances in inflammatory bowel disease.Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients.Bax is downregulated in inflamed colonic mucosa of ulcerative colitis.Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.Effects of garlicin on apoptosis in rat model of colitisAppendix is a priming site in the development of ulcerative colitis.Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis.Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.Colonic epithelial cell turnover: possible implications for ulcerative colitis and cancer initiation.Increased presence of effector lymphocytes during Helicobacter hepaticus-induced colitisSustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cellsA new chronic ulcerative colitis model produced by combined methods in ratsMechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis.Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease.Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis.Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD.Biologic targeting in the treatment of inflammatory bowel diseases.Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease.Molecular pathways driving disease-specific alterations of intestinal epithelial cells.Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors.Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestineIntraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.Cyclosporine regulates intestinal epithelial apoptosis via TGF-beta-related signaling.NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines.Cytokine regulation of human intestinal primary epithelial cell susceptibility to Fas-mediated apoptosis.Tumor necrosis factor alpha up-regulates non-lymphoid Fas-ligand following superantigen-induced peripheral lymphocyte activation.Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet's disease but not VKH syndrome in Han Chinese.Serum m 30 levels reflects ulcerative colitis activity.Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery.
P2860
Q24597407-44006136-C304-476C-9261-F2B705460EA8Q27016000-9FAA6C2F-21EA-47BA-955F-5A1350508A9CQ33699974-8C2559D2-553C-4AF0-A2D2-1C529F26CBB1Q33745917-F848C928-DE72-42D6-87DC-00302F2AAC20Q33860215-D93C10BF-E9B5-439F-A77A-04088C98E756Q33865593-FA671495-3FAD-491A-B679-2D7E1A8F7262Q34015892-827BC03C-D0D3-42B1-991A-6C0F2252B76CQ34024008-46232CAC-CEC5-45B5-8EF7-888260A9B96BQ34121359-F2B04E79-4B35-442A-B096-E340304B0B7EQ34188405-4923F803-1DCD-453E-B77E-1E6C7A3E55F0Q34382340-8B08DA9E-2525-42B9-8F4C-273F754CDCC9Q35360957-87A0A10A-45C2-4D78-89BD-0B52CD6C0C04Q35364122-F98227CB-24DF-4E5B-85D6-2143BD0A3EEBQ35435541-5AA8A8B0-85A9-4CBB-9C2C-2CC75145412BQ35435811-931AE0B5-4D36-42D8-B711-F6539C9C630EQ35594988-10A7D110-5BD1-4FE1-9393-682ECCB0B6A1Q35596945-87A8111B-654C-495D-B8D7-D05A06BFA39CQ35742033-4F7EFF04-7C76-4EEC-84F7-016970E0AF96Q35872044-C31A31D7-8BEC-4599-BCFD-85EA77EDD055Q36293736-F21DCEAE-98E0-4661-97AE-59CEFCCCF9AEQ36397733-464F2C06-C97F-4220-ACB2-16B9FE3EA904Q36474134-AD7B419A-FC93-443A-B612-CBE147ED77D5Q36627435-0A52AA1B-1632-4935-AA95-384B61737D20Q36774486-843B7F60-92C6-40B5-8FB4-C5C177E36FD1Q37290315-A3941384-44E7-4988-9636-BC40BAC0C453Q37303206-DEEF3B07-D661-47F9-9B51-4FEC0692B850Q37680981-DB54898A-752B-4EFA-8B6D-87DC39FB95C4Q38901703-052B899A-6FB0-4BEE-8FFE-3B721EBF4A3EQ38953543-C377ADDC-4041-44EA-B572-94108A1CBCFBQ40933974-FFD9B867-B921-464C-B572-9EBD8FBC5B9EQ41824084-73A96927-1F73-4A4A-959F-80B899E53E49Q41839820-D105F81C-17D9-4150-A7C5-F554868AE859Q41861964-B7AB81C9-2C46-43CB-A2C2-198540B06628Q43673136-1F20A651-0E10-4319-9EAF-9820884EE4C4Q43716993-85ABE98B-D9B6-4803-A0DA-01A77C6E8403Q43829137-2E76293A-4363-4C5A-9323-1BE02FB48FE0Q46209441-2AFD5048-52DD-44FC-BB14-95D28EC37727Q47129890-1893F2D5-4918-496E-B736-81901E771B7CQ47779699-53DD5D62-2D1D-4778-8208-11B59EC25ED1Q52546687-4D55B1AD-2984-4E79-B1B4-469F25870E40
P2860
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@ast
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@en
type
label
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@ast
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@en
prefLabel
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@ast
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@en
P2093
P2860
P356
P1433
P1476
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
@en
P2093
Ishikawa H
Kanayama S
Kitamura S
Kiyohara T
Matsuzawa Y
Miyagawa J
P2860
P356
10.1136/GUT.43.1.48
P407
P577
1998-07-01T00:00:00Z